Company Overview of Leerink Partners LLC
Leerink Partners LLC is a boutique investment banking firm that offers financial advisory services to the healthcare industry. The firm offers private placements, initial public offerings, PIPEs, valuation and fairness opinions, due diligence, and mergers and acquisitions advisory services. Additionally, it provides institutional sales and trading management, cash management, company transformation, turnaround management, and marketing strategy development services. Leerink Partners LLC was formerly known as Leerink Swann LLC and changed its name to Leerink Partners LLC in January 2014. The firm was founded in 1995 and is based in Boston, Massachusetts with additional offices in New York, Ne...
One Federal Street
Boston, MA 02110
Founded in 1995
Key Executives for Leerink Partners LLC
Chairman of The Board and Chief Executive Officer
President and Head of Investment Banking
Managing Director and Head of Marketing
Senior Managing Director and Head of Leerink Swann Strategic Advisors
Compensation as of Fiscal Year 2015.
Leerink Partners LLC Key Developments
Leerink Partners LLC Announces Management Changes
May 12 15
LEERINK Partners announced that it has expanded its investment banking franchise with the hiring of four senior bankers and their teams, who were all previously at Lazard Middle Market. Doug Brown, Senior Managing Director, will lead the Healthcare Services and Private Equity Coverage franchises at LEERINK. Mike Drendel, Managing Director, will lead the Specialty & Generic Pharmaceuticals franchise. Jeff Danesis, Director, will focus on Healthcare Services and Byron Webster, Director, will focus on Specialty & Generic Pharmaceuticals. These experienced bankers bring considerable healthcare mergers and acquisitions advisory experience and extensive sector and private equity relationships to LEERINK Partners. The newly formed Charlotte, North Carolina office will have 10 investment banking professionals.
Leerink Partners LLC Presents at BIO-Europe Spring 2015, Mar-09-2015
Jan 29 15
Leerink Partners LLC Presents at BIO-Europe Spring 2015, Mar-09-2015 . Venue: Paris Expo - Porte de Versailles, Hall 5, Paris, France.
Leerink Partners Appoints James Boylan as President
Jan 12 15
Leerink Partners appointed James Boylan as President. Mr. Boylan will retain the title of Head of Investment Banking and will oversee Sales and Trading. Mr. Boylan has served on Leerink’s management committee since 2009. He will continue to be based out of New York. Mr. Boylan has 20 years of experience in healthcare investment banking. Prior to joining Leerink in 2009 as a Senior Managing Director and Head of Investment Banking, Mr. Boylan was a Managing Director at Merrill Lynch for over a decade. At Leerink Partners, Mr. Boylan continues to work with and advise innovative and growth oriented healthcare companies on M&A and capital formation strategies and transactions.
Similar Private Companies By Industry
Recent Private Companies Transactions